Adult Use Cannabis in Michigan Approved by Voters

Adult Use Cannabis in MichiganDuring the November election, 56% of voters passed Proposal 1 making adult use cannabis in Michigan a reality. Spearheaded by the Coalition to Regulate Marijuana Like Alcohol, the effort to pass the Michigan Regulation and Taxation of Marihuana Act (MRTMA) started with 277,370 certified voter signatures that got the proposal on the midterm ballot. What comes next is still up in the air.

At Medicine Man Technologies, we are hopeful that state lawmakers will move more quickly than they have since voters passed a medical cannabis bill in 2008. A basic framework and regulations took nearly 10 years to develop and the newly established Medical Marihuana Licensing Board didn’t begin taking applications for growers, transporters, dispensaries and other operations until December 2017.

In addition, changes continue to hinder the market. Right now, unlicensed medical dispensaries are operating under temporary emergency rules while they await state approval. Many purchase cannabis from a network of 40,000 registered caregivers who can legally grow up to 72 plants for their patients and sell their excess to dispensaries. Because of recent changes to the laws, once dispensaries are fully licensed, they will not be allowed to purchase cannabis from caregivers after 30 days.

Meanwhile, growers are still in the process of licensing and establishing their operations, much less cultivating. Supply shortages are inevitable and some dispensaries could be forced out of business.

With that being said, how will adult use cannabis in Michigan move forward?

A Quick Overview of What Prop 1 Covers

While recreational cannabis will be legal as of December 6, Michigan’s Department of Licensing and Regulatory Affairs will first need to focus on setting up the state’s framework and won’t begin licensing businesses (growers, retailers, processors, etc.) until December of 2019.

That means residents will likely have to wait until 2020 for retail sales to begin – longer if roadblocks similar to the state’s medical cannabis program arise. In the meanwhile, here’s what MRTMA covers:

  • Michigan adults, 21 years of age and older, will be allowed to possess, transport and use (only in a private setting) up to 2.5 ounces of cannabis or 15 grams of concentrate.
  • Adults may grow a maximum of 12 cannabis plants inside their home or a secured, outdoor area that’s hidden from public view (such as from the street).
  • Each household is allowed up to 10 ounces of dried cannabis flower for personal use, however, anything over 2.5 ounces must be kept in a locked container.
  • Adults may also transfer, without payment, up to 2.5 ounces or 15 grams of concentrate to another adult. Unlicensed sales by an individual are illegal.
  • Landlords can decide if tenants are allowed to grow or use cannabis inside their rental units.
  • The laws for adult use cannabis in Michigan does not provide any disciplinary protection from an employer’s drug policies, testing requirements, or working under the influence.
  • Operating any type of vehicle under the influence of cannabis is illegal.
  • Like alcohol, anyone under the age of 21 is prohibited from possessing or using cannabis, and it’s illegal to transfer or purchase it for anyone underage.

Once the program is launched, there will be a 10% excise tax on top of the current 6% sales tax for all sales. This will first go towards funding the ongoing operations of Michigan’s Department of Licensing and Regulatory Affairs. Another $20 million is earmarked until 2022 to research the use of cannabis in treating U.S. military veterans and preventing suicides. The remaining will be split between cities and counties based where cannabis-based businesses are located, as well as schools and transportation.

At Medicine Man Technologies, we were excited to see voters embrace adult use cannabis in Michigan. And we can only hope that it won’t take another 10 years for state officials and lawmakers to develop the foundation and launch a properly working system.

If you wish to start your own legal enterprise in the U.S. or anywhere across the globe, please contact us for private consulting, as well as help with licensing, cultivating, dispensary operations and more.

Medical Cannabis Makes Its Way to Eastern Europe

Medical Cannabis in LithuaniaIn October, medical cannabis in Lithuania was legalized by the country’s Parliament. While it will not go into effect until May of 2019, it will allow doctors to prescribe cannabis to treat a number of conditions. The legislation is expected to be officially signed into law by the country’s president, Dalia Grybauskaite.

Medicine Man Technologies has been watching the progress of this bill since November of 2017 when it was introduced by Lithuanian MP, Mykolas Majauskas. A member of the country’s conservative party, Homeland Union, Majauskas emphasized the need to change the laws in order to help patients forced to use, “morphine, opioid-based medicines, on a daily basis, when they can take cannabis medicines that are significantly less harmful [instead].”

To move the bill forward, lawmakers first amended the country’s laws on Pharmacy and Narcotic Drugs and Psychotropic Substances. Previously, cannabis was listed in the same category as highly addictive drugs such as heroin, opium, MDMA, cocaine and morphine. Possession of a small quantity came with a harsh penalty of up to 2 years in prison and growing for personal use could be punished with 5 years.

As the legislation gained momentum and moved through its phases, Majauskas was asked about what he predicted for medical cannabis in Lithuania. He stated, “In the longer term, I am confident we will be growing cannabis, producing food supplements, conducting clinical research, and making the best possible medicine for our patients. For the time being, we expect to import registered pharmaceuticals from other EU countries, just as many other countries do.”

While May 2019 is a long way out and changes to the law are certainly possible, here’s what we know at this point. All cannabis-based medications will need to be registered with Lithuania’s National Medicine Control Agency and their efficacy backed by scientific research. The agency will also be responsible for granting licenses to sellers and distributing permits for clinical trials.

Doctors may issue medical cannabis prescriptions for patients who have cancer, HIV/AIDS, multiple sclerosis (MS), severe or rare forms of epilepsy, or autoimmune diseases. Recreational use will remain illegal.

Medicine Man Technologies will continue to monitor medical cannabis in Lithuania in hopes that the current launch date will be moved up and the program expanded to include more conditions. For now, we’re excited to see this small country adopt a progressive stance in providing compassionate care.

If you wish to start your own legal enterprise in the U.S. or anywhere across the globe, please contact us for private consulting, as well as help with licensing, cultivating, dispensary operations and more.

Medical Cannabis in the UK Inches Forward After Controversy

Medical Cannabis in the UKDrug policy reform in the United Kingdom is notoriously slow, more or less non-existent, which makes its most recent steps forward highly surprising. While change only came about after a public backlash over the confiscation of legally obtained CBD oil for a 12-year-old boy with severe epilepsy, medical cannabis in the UK is now available for patients with specific and extreme circumstances.

Medicine Man Technologies watched the story unfold this June when Charlotte Caldwell, the mother of a young boy who endured nearly 100 epileptic seizures each day, flew to Canada to legally purchase a high-CBD, low-THC oil to treat his condition. She publicly announced her plan to challenge Britain’s ban on medical cannabis by openly “smuggling” her son’s medication back through customs.

Ms. Caldwell had this to say, “I will ask them if they will let me keep this safe, regulated medicine that has kept my little boy alive – or are they going to take it off me, condemning my son to possible death? If they confiscate Billy’s medicine and arrest me, they are signing his death warrant.”

As feared, the CBD oil was confiscated by authorities at London’s Heathrow Airport. Caldwell then met with the UK Minister of State for Policing, Nick Hurd, who denied her request to have the oil returned.

What’s perplexing is that Caldwell’s son, Billy, was actually the first patient to be granted a prescription for medical cannabis by the National Health Service in the UK after first being successfully treated in the United States. However, Billy’s doctor was threatened with disbarment by the Home Office, British law enforcement, and the family was forced to seek out medical cannabis elsewhere – Canada.

Inevitably, after Billy’s medication was confiscated, the lack of treatment caused Ms. Caldwell’s son to suffer his first seizure in over a year. The episode was recorded and posted to social media where their plight gained worldwide attention and generated pressure on lawmakers to address medical cannabis in the UK. The stakes were soon raised when Billy was admitted to the hospital in severe condition.

Finally, government officials at the Home Office realized that they could no longer deny the boy his life-saving medication. Billy was granted a license that allows him to break the law and access the CBD oil he needs. It was also given to another boy, Alfie Dingley, facing similar circumstances.

According to Sajid Javid, Home Secretary of the United Kingdom, “Recent cases involving sick children made it clear to me that our position on cannabis-related medicinal products was not satisfactory. That is why we launched a review and set up an expert panel to advise on license applications in exceptional circumstances. This will help patients with an exceptional clinical need but is in no way a first step to the legalization of cannabis for recreational use.”

In October, Javid announced that medical cannabis in the UK would be rescheduled under its drug laws and available for patients by prescription as of November 1.

What Medication is Available for UK Patients Today?

The National Health Service has since clarified that very few people will qualify for a prescription of medical cannabis in the UK.

The first hurdle is that it must be prescribed by a specialist, not a general practitioner, on a case-by-case basis. And at this point, the only conditions that would likely qualify are severe or rare forms of epilepsy in children and adults with vomiting or nausea caused by chemotherapy. Another possible application is for spasticity due to multiple sclerosis (MS) only when other treatments have not helped.

In fact, the first round of clinician guidelines provided by the Royal College of Physicians and the Royal Paediatric Neurology Association clearly state that, “cannabis-based products for medicinal use should only be prescribed for indications where there is clear published evidence of benefit or UK Guidelines and in patients where there is a clinical need which cannot be met by a licensed medicine and where established treatment options have been exhausted.”

These limitations have been perceived as overly restrictive and are compounded by the longstanding prohibition of medical cannabis in the UK which means many doctors are not aware of existing studies on efficacy or trained on treatment options and dosages. The likely result is that very few patients will receive their much-needed medication until further research has been done and training implemented.

Here at Medicine Man Technologies, we absolutely would like to see more progress made in the very near future. However, thinking back to just a year ago, we would never have imagined the UK making this small step forward. It’s our hope that given time, they will embrace and empower a legal medical cannabis market for the sake of Billy Caldwell, Alfie Dingley and all of its citizens in need.

If you wish to start your own legal enterprise in the U.S. or anywhere across the globe, please contact us for private consulting, as well as help with licensing, cultivating, dispensary operations and more.

Northern Mariana Islands Legalizes Cannabis, Makes History

CNMI flagOn September 21, 2018, the Commonwealth of Northern Mariana Islands (CNMI) became the first U.S. territory to legalize adult use cannabis through legislative action rather than a public ballot vote. Considering this group of small islands in the Pacific has a Republican-controlled congress and governor, Medicine Man Technologies was surprised to see such sweeping and progressive reform.

Governor Ralph Torres, signed the Taulamwaar Sensible CNMI Cannabis Act of 2018 into law after the Senate passed it 6-0-2 and the House approved it 18-1-1. He stated, “Today, our people made history. We took a stand to legalize marijuana in the CNMI for recreational, medical, and commercial use.”

The governor’s sign-off comes just months after he raised concerns about how legalization would affect public safety, requesting a look at crime rates in states where cannabis had been legalized. Fortunately, available data for such states actually shows a decrease in violent crime which likely placated his fears.

What’s Included in the New CNMI Law

Now, a 5-person Cannabis Commission must be established to act as the regulatory agency for cannabis and hemp. It’s main duty in the first 180 days will be establishing and implementing new rules, as well as licensing six types of cannabis businesses: production, processing, testing facilities, wholesale, retail and lounges. While it will take time to establish the CNMI market, let’s take a look at a few highlights.

Adults 21 Years of Age and Older:
  • May possess and transport up to 1 ounce of cannabis, 16 ounces of infused products in solid form or 72 ounces in liquid form, and 5 grams of extracts.
  • Except for medical cannabis, may not possess or use in a government building or on federal property, on any school or college property (except for research), or at an establishment that is allowed to serve alcohol.
  • Registering with the Homegrown Marijuana Registry for adults, patients and caregivers will be required. However, if it’s not created with 120 days of the Cannabis Commission’s organizational meeting, adults may start growing (6 mature, 12 immature plants) and register once available.
  • Medical marijuana will require a physician’s recommendation and one qualifying condition such as cancer, glaucoma, HIV/AIDS, PTSD, Parkinson’s disease, cerebral palsy and many more.
  • Consuming cannabis in public or in the presence of anyone under the age of 21 is prohibited and may garner a first-time fine of $250 and $1,000 for further violations.
  • Consuming while driving (including boats and other modes of transport), underage possession, importing/exporting, and excess possession are subject to various fines and/or imprisonment.
For Cannabis-Related Businesses:
  • Applicants for licenses must have continued residency in the CNMI for 10+ years unless they were away due to educational training or military service.
  • May not be located within 500 feet of a church, school building, hospital, clinic or youth center.
  • Only producers and micro-producers (25 plants or less) may possess and sell mature plants.
  • An individual may apply for and hold multiple licenses – however, you may only hold one micro-producer and one testing license at any given time.
  • All applications must be submitted with a $250 processing fee. Licenses for micro-producers are $250. For all other businesses, it was originally $4,500 but Gov. Torres vetoed this provision and requested that it be set higher.
  • There will be a 10% ad valorem tax on cannabis grown in the commonwealth. Taxes and fees for producers, and an excise tax for retailers will be enacted at a later date.

Once the Cannabis Commission convenes for its organizational meeting, there will be a 180-day timeline to begin implementing the new program in the CNMI. Fortunately, the detailed rules already outlined in the approved bill provide a great head start, and Medicine Man Technologies is confident that residents will soon have access to the medicines they need, as well as be able to freely enjoy adult-use cannabis.

If you wish to start your own legal enterprise in the U.S. or anywhere across the globe, please contact us for private consulting, as well as help with licensing, cultivating, dispensary operations and more.

Country of Georgia Legalizes Cannabis Consumption

cannabis in GeorgiaConsumption of cannabis in Georgia, former member of the now-dissolved Soviet Union, was officially legalized in July after a ruling by the country’s Constitutional Court. This follows a 2017 decriminalization decision that abolished harsh punishments for cannabis use. At Medicine Man Technologies, we agree that it’s a step in the right direction though broader reform needs to be implemented.

The case was led by plaintiffs and activists, Vakhtang Megrelishvili and Zurab Japaridze, party leader for Girchi or the New Political Center which leans libertarian. They argued that cannabis consumption was an individual freedom and that the consumer is accountable for any effects on their health. More importantly, they contended that consumption did not threaten society at large, thus making it unconstitutional to impose any type of penalty for personal use.

The court agreed, and while the ruling did not legalize cultivation or sales, the consumption of cannabis in Georgia will no longer be subject to administrative penalties such as fines.

However, the court did recognize that there may be situations where consumption does pose a risk to others, and those acts will be subject to punishment. Their ruling stated, “…the Constitutional Court highlights the imposition of responsibility of marijuana consumption when it creates a threat to third parties. For instance, the Court will justify responsibility when marijuana is consumed in educational institutions, public places, such as on public transport, and in the presence of children.”

Cultivating and Exporting Cannabis in Georgia? Not So Fast.

Despite the ruling, support for additional progress has stalled despite Georgia’s Finance Minister, Ivane Machavariani, stating that if the country were to cultivate and export cannabis for pharmaceutical and cosmetic products, it could generate profits of over 1B Georgian Lari (GEL) or over $383 million (USD) in just two or three years.

The country’s current ruling party, Georgian Dream – Democratic Georgia, actually drafted legislation to capitalize on the opportunity, and it was presented to Georgia’s parliament by the Ministry of Internal Affairs on September. The goal was to create a regulated licensing program with typical rules regarding location, cultivation amounts, processing and all other necessary activities to support an export market.

The bill was widely criticized for the hypocritical nature of cultivation for export and government profit but not for legal buying and selling now that personal use has been legalized. “[The government] wants to produce it while punishing others for [using] it? This is absurd,” said Giga Bokeria of the European Georgia Party.

Zurab Japaridze, one of the plaintiffs from July’s Constitutional Court case, also reacted, “The use of marijuana is legal and there should be legal ways for obtaining legal substances. Marijuana production should become a usual business; it may be regulated but not monopolized.”

Adding more fuel to the controversy, the influential Georgian Orthodox Church also protested moving forward with further legalization of cannabis in Georgia. Current Catholicos-Patriarch of All Georgia, Ilia II, had said, “We must not regard profit alone. Why do we need such an economy if we lose our children?” He then urged government officials to rethink their plans and proceed with extreme caution.

In response, Parliament Speaker, Irakli Kobakhidze, postponed further discussion by lawmakers. Instead, the focus will be on informing citizens about further legalization and consulting with the Patriarchate to gain their support moving forward. He stated, “The society is not properly informed; there are false information being spread, there are speculations, so we need to pay particular attention to informing the public and decide [on the legislation] together with them.”

Like many other countries, it seems that legalizing cannabis in Georgia is just the beginning of a much bigger fight to bring true reform. Medicine Man Technologies hopes to see their government move ahead, with or without the support of the Church, to establish both a thriving export market and a system to provide citizens with full legal access to cannabis.

If you wish to start your own legal enterprise in the U.S. or anywhere across the globe, please contact us for private consulting, as well as help with licensing, cultivating, dispensary operations and more.


Ryan Allway | CFN Media Group (October 3 2016) Medicine Man (MDCL): Building a Leading Cannabis Brand Warehouse

Matt Koesters | WCPO contributor (September 25 2016) Could marijuana become a treatment for heroin addicts?

ABC 6 On Your Side, By Liz Bonis, WKRC (September 8 2016) Can medical marijuana help addicts transition off heroin and opioids? (September 8 2016) Colorado marijuana businesses optimistic about Ohio medical marijuana law (video)

Forbes Magazine (August 27, 2016) Act 16 legalized Medical Marijuana in PA! How Long Till Patients Have Access?

Forbes Magazine (August 27, 2016) Four Cannabis Entrepreneurs Share Their Strangest Moments

New Cannabis Ventures (August 12, 2016) Medicine Man Technologies to Issue $12.6mm in Stock to Buy Pono Publications and Success Nutrients

The Denver Post (July 28, 2016) Marijuana industry ditches burnout image for “suit and tie” approach to DNC

Leafbuyer (July, 2016) Leafbuyer presents The 2016 Power List

OEN (June 27, 2016) Pot-Powered Family Business, Growing Like a Weed in Denver

Philly Voice (May 20, 2016) – This weekend, the business of pot comes to Philly

Inc. ( April 20, 2016) – The Marijuana Business Is Really the Real Estate Business

MJINews – Marijuana Investor News (April 15, 2016) Medicine Man Technologies Inc. Shows A Profit In Its First Full Year Of Operations

Marijuana Business Daily (April 14, 2016) With Pennsylvania Medical Marijuana a Reality, Attention Turns to Regulations

New Cannabis Ventures ( April 2, 2016) 7 Experts Discuss Best Practices On Taking Your Cannabis Company Public

PR NewsWire (March 23, 2016) Medicine Man Technologies to Present at MoneyShow Cannabis Investing Virtual Event on March 30

New Cannabis Ventures (March 23, 2016) Cannabis Investing Virtual Event Features Canopy Growth, MassRoots and Medicine Man Technologies

US News and World Reports (March 17, 2016) How to Invest in Marijuana Legalization

Marijuana Business Daily (January 5, 2016) A Look Ahead: Marijuana Retail, Cultivation & Industry Trends to Watch in 2016

Westword (September 14, 2015 )Taking Stock of Colorado’s Marijuana Industry – Westword Magazine article about Medicine Man Technologies becoming a publicly traded company

CFN Media Group CFN Interview with Andy Williams – CEO of Medicine Man

CNN (January 24, 2015) Colorado’s Booming Marijuana Industry – Medicine Man was featured in this recent CNN story about our Grow Technology.

The Denver Post (January 19, 2014): Family-owned pot shop in Denver seeks to become national player

The Denver Post (June 15, 2014): Reluctance of banks leaves pot shops looking for secure practices

TIME Magazine: Pot’s Money Problem

Playboy: Chronic Insecurity

Denver Business Journal: Colorado’s dispensaries will be its first recreational marijuana sellers as well

Orlando Business Journal: 5 ways to capitalize on medical marijuana

Natural Products Insider: Recreational Marijuana: How One Denver Dispensary Is Soaring to New Highs A Look at Medicine Man, One of Colorado’s Largest Marijuana Dispensaries

Fox 31 Denver: Colorado pot pioneers will soon rake in the green

BBC News Tour: Inside a Colorado marijuana factory

NBC’s Today Show: Medicine Man Denver on The Today Show 1-27-14

Katie Couric Show: Katie Couric Goes Inside a Marijuana Store